Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy
Genre
Journal articleDate
2022-06-22Author
Barohn, Richard J.Allen, Jeffery
Avila, David
Barboi, Alexandru
Biliciler, Suur
Abrams, Charles
Brannigan, Thomas, III
Cartwright, Michael
Chahin, Nizar
Chawla, Jasvinder
Chuquilin, Miguel
Collins, Michael
Deboo, Anahita
England, John
Fernandes, Joseph
Friemer, Miriam
Geisler, Stefanie
Herskovitz, Steven
Holland, Neil
Jackson, Carlayne
Juel, Vern
Lacomis, David
Levy, Maxwell
Malik, Rabia
Menichella, Daniela
Nations, Sharon
Peltier, Amanda
Pulley, Michael
Rezania, Kourosh
Robinson-Papp, Jessica
Ruzhansky, Katherine
Sharma, Khema
Stino, Amro
Su, Xiaowei
Swenson, Andrea
Thaisetthawatkul, Pariwat
Thawani, Sujata
Traub, Rebecca
Department
NeurologySubject
LetterPermanent link to this record
http://hdl.handle.net/20.500.12613/10401
Metadata
Show full item recordDOI
http://dx.doi.org/10.17161/rrnmf.v3i2.18133Citation
Barohn, R. J., Abrams , C. K., Allen , J. A., Ashraf, K., Avila, J. D., Barboi, A., Bartlett, G., Bensman, J., Biliciler , S., Brannagan III, T. H., Brown, A., Callaghan, B., Cartwright , M. S., Cassone, D., Chahin, N., Chawla, J., Christie, M., Chuquilin, M. ., Collins, M. P., … Waitman, L. R. (2022). Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy. RRNMF Neuromuscular Journal, 3(2), 45-98. https://doi.org/10.17161/rrnmf.v3i2.18133Citation to related work
The University of KansasHas part
RRNMF Neuromuscular Journal, Vol. 3, No. 2ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduCollections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND